“Cipla today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc, and Exelan Pharmaceuticals Inc,” said the Mumbai-based pharma company in its filing.
Posts tagged MC
Cipla to acquire two US pharma companies for $550 mn (04-09-2015)
Buy if Nifty goes above 7860; bullish Geometric: Rajat Bose (04-09-2015)
Rajat Bose of rajatkbose.com recommends traders to buy Geometric and Repco Home Finance
Nifty can fall at opening bell: Maximus Securities (04-09-2015)
Trading of CNX Nifty futures on the Singapore stock exchange indicates that the Nifty could loose 25.5 points at the opening bell, says Maximus Securities.
Expect market to open on flat note: Angel Broking (04-09-2015)
According to Angel Broking, markets are expected to open flat tracking the SGX Nifty and global cues.
See flat to negative opening: ICICIdirect (04-09-2015)
Nifty is likely to open flat to negative on the back of mixed global cues. It is likely to trade in the range of 7800-7900, according to a report by ICICIdirect.
See more downside to EMs if Fed hikes rates: Rabobank (04-09-2015)
Micheal Every of Rabobank expects the US non-farm payroll data to come in at 217,000 in August versus 215,000 In July.
UTI Mutual Fund looking to cross Rs 1.1 tn mark by FY-end (04-09-2015)
It was on July 4 that the fund house crossed the mark of Rs 1 trillion in terms of asset under management (AUM), which currently stands at Rs 1,03,800 crore.
JCHAC to acquire 72% of Hitachi Home and Life Solution (04-09-2015)
JCHAC India Holdco, a wholly-owned subsidiary of Japanese giant Hitachi Appliances, would acquire the said stake.
Stocks in news: Wipro, Cipla, Jyothy Lab, Glenmark, Leyland (04-09-2015)
Wipro | Cipla | Jyothy Labs | Edelweiss Financial | Power Finance Corporation | Pfizer | NBCC | Power Mech | Glenmark Pharma | NMDC | Ashok Leyland | SBI | Raymond and Gayatri Projects are stocks, which are in the news today.
Bull’s Eye: Buy Voltas, Escorts, MphasiS, Punj Lloyd, HDIL (04-09-2015)
Jay Thakkar of Sharekhan advises buying MphasiS with a target of Rs 444.